Radiance Research AcademyInternational Journal of Current Research and Review2231-21960975-5241EnglishN2023July24HealthcareChalcones as Next-generation Antimicrobial Agents: Deep Insights into Anti-infective Perspectives and Novel Synthesis Routes English0106Amit VaishnavEnglish Pushpraj OgreEnglishMr. Amit Vaishnav, Post-Graduate Student, Department of Pharmaceutical Chemistry, School of Pharmacy, Chouksey Engineering College, Bilaspur 495004, Chhattisgarh, Indiahttps://doi.org/10.31782/IJMPS.2023.13701Chalcones, containing an α,β-unsaturated ketone fragment, are an important pharmacologically active agents because of their diverse mechanisms. The antibacterial activity of natural and manufactured chalcones has recently undergone some changes, and this study gives an update on those changes. Understanding the mechanisms of action of various processes, compounds, or drugs is essential for advancing scientific knowledge and facilitating the design and synthesis of new treatments and interventions. When researchers comprehensively summarize the mechanisms of action, it can offer critical insights and guidance for future studies and developments. This all-encompassing and evaluative analysis will offer valuable insights to medicinal chemists aiming to enhance the creation of potential antibacterial agents. EnglishChalcone, Antimicrobial, Antiinfective, Synthesis, Pharmacology, Naturalhttp://ijcrr.com/abstract.php?article_id=230http://ijcrr.com/article_html.php?did=2301. D.J. Newman, G.M. Cragg, Natural products as sources of new drugs from 1981 to 2014, J. Nat. Prod. 79 (2016) 629−661. 2. C.L. Zhuang, W. Zhang, C.Q. Sheng, W.N. Zhang, C.G. Xing, Z.Y. Miao, Chalcone: a privileged structure in medicinal chemistry, Chem. Rev. 117 (2017) 7762−7810. 3. P. Singh, A. Anand, V. Kumar, Recent developments in biological activities of chalcones: a mini review, Eur. J. Med. Chem. 85 (2014) 758−777. 4. Z. Nowakowska, A review of anti-infective and antiinflammatory chalcones, Eur. J. Med. Chem. 42 (2007) 125−137. 5. M.J. Matos, S. Vazquez-Rodriguez, E. Uriarte, L. Santana, Potential pharmacological uses of chalcones: a patent review (from June 2011–2014), Expert Opin. Ther. Pat. 25 (2015) 351−366. 6. Nasir Abbas Bukhari S, Jasamai M, Jantan I, Ahmad W. Review of methods and various catalysts used for chalcone synthesis. Mini Rev Org Chem. 2013;10(1):73-83. 7. Farooq S, Ngaini Z. Recent synthetic methodologies for chalcone synthesis (2013-2018). Curr Organocatal. 2019;6(3):184-92. 8. Jasim HA, Nahar L, Jasim MA, Moore SA, Ritchie KJ, Sarker SD. Chalcones: synthetic chemistry follows where nature leads. Biomolecules. 11 (2021) 1203. 9. M. Ayman, S.M. El-Messery, E.E. Habib, S.T. Al-Rashood, A.A. Almehizia, H.M. Alkahtani, G.S. Hassan, Targeting microbial resistance: Synthesis, antibacterial evaluation, DNA binding and modeling study of new chalcone-based dithiocarbamate derivatives, Bioorg. Chem. 85 (2019) 282−292. 10. T.Y. Zhang, Z.K. Yu, X.J. Jin, M.Y. Li, L.P. Sun, C.J. Zheng, H.R. Piao, Synthesis and evaluation of the antibacterial activities of aryl substituted dihydrotriazine derivatives, Bioorg. Med. Chem. Lett. 28 (2018) 1657−1662. 11. P. Yadav, K. Lal, L. Kumar, A. Kumar, A. Kumar, A.K. Paul, R. Kumar, Synthesis, crystal structure and antimicrobial potential of some fluorinated chalcone-1,2,3-triazole conjugates, Eur. J. Med. Chem. 155 (2018) 263−274. 12. M.M. Zhang, A.M. Prior, M.M. Maddox, W.J. Shen, K.E. Hevener, D.F. Bruhn, R.B. Lee, A.P. Singh, J. Reinicke, C.J. Simmons, J.G. Hurdle, R.E. Lee, D.Q. Sun, Pharmacophore modeling, synthesis, and antibacterial evaluation of chalcones and derivatives, ACS Omega 3 (2018) 18343−18360. 13. S.A. Khan, A.M. Asiri, Green synthesis, characterization and biological evaluation of novel chalcones as anti bacterial agents, Arab. J. Chem. 10 (2017) S2890−S2895. 14. V. Desai, S. Desai, S.N. Gaonkar, U, Palyekar, S.D. Joshi, S.K. Dixit, Novel quinoxalinyl chalcone hybrid scaffolds as enoyl ACP reductase inhibitors: synthesis, molecular docking and biological evaluation, Bioorg. Med. Chem. Lett. 27 (2017) 2174−2180. 15. S.D. Joshi, S.R. Dixit, M.N. Kirankumar, T.M. Aminabhavi, K.V.S.N. Raju, R. Narayan, C. Lherbet, K.S. Yang, Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties, Eur. J. Med. Chem. 107 (2016) 133−152. 16. M. Kucerova-Chlupacova, V. Vyskovska-Tyllova, L. Richterova- Finkova, J. Kunes, V. Buchta, M. Vejsova, P. Paterova, L. Semelkova, O. Jandourek, V. Opletalova, Novel halogenated pyrazine-based chalcones as potential antimicrobial drugs, Molecules 21 (2016) 1421. 17. R. Kant, D. Kumar, D. Agarwal, R.D. Gupta, R. Tilak, S.K. Awasthi, A. Agarwal, Synthesis of newer 1,2,3-triazole linked chalcone and flavone hybrid compounds and evaluation of their antimicrobial and cytotoxic activities, Eur. J. Med. Chem. 113 (2016) 34−49. 18. R. Gaur, V.K. Gupta, A. Pal, M.P. Darokar, R.S. Bhakuni, B. Kumar, In vitro and in vivo synergistic interaction of substituted chalcone derivatives with norfloxacin against methicillin resistant Staphylococcus aureus, RSC Adv. 5 (2015) 5830−5845. 19. L. Feng, M.M. Maddox, M.Z. Alam, L.S. Tsutsumi, G. Narula, D.F. Bruhn, X.Q. Wu, S. Sandhaus, R.B. Lee, C.J. Simmons, Y.C. Tse-Dinh, J.G. Hurdle, R.E. Lee, D.Q. Sun, Synthesis, structure− activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives, J. Med. Chem. 57 (2014) 8398−8420. 20. M.I. Abdullah, A. Mahmood, M. Madni, S. Masood, M. Kashif, Synthesis, characterization, theoretical, anti-bacterial and molecular docking studies of quinoline based chalcones as a DNA gyrase inhibitor, Bioorg. Chem. 54 (2014) 31−37. 21. S.N. Shelke, G.R. Mhaske, V.D.B. Bonifácio, M.B. Gawande, Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives, Bioorg. Med. Chem. Lett. 22 (2012) 5727−5730. 22. X. Jin, C.J. Zheng, M.X. Song, Y. Wu, L.P. Sun, Y.J. Li, L.J. Yu, H.R. Piao, Synthesis and antimicrobial evaluation of L-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4- thiazolidinone, Eur. J. Med. Chem. 56 (2012) 203−209. 23. T.D. Tran, T.T.N. Nguyen, T.H. Do, T.N.P. Huynh, C.D. Tran, K.M. Thai, Synthesis and antibacterial activity of some heterocyclic chalcone analogues alone and in combination with antibiotics, Molecules 17 (2012) 6684−6696. 24. T.M. Osório, F.D. Monache, L.D. Chiaradia, A. Mascarello, T.R. Stumpf, C.R. Zanetti, D.B. Silveira, C.R.M. Barardi, E.F.A. Smânia, A. Viancelli, L.A.T. Garcia, R.A. Yunes, R.J. Nunes, A. Smânia, Antibacterial activity of chalcones, hydrazones and oxadiazoles against methicillin-resistant Staphylococcus aureus, Bioorg. Med. Chem. Lett. 22 (2012) 225−230. 25. X. Jin, C.J. Zheng, M.X. Song, Y. Wu, L.P. Sun, Y.J. Li, L.J. Yu, H.R. Piao, Synthesis and antimicrobial evaluation of L-phenylalanine-derived C5-substituted rhodanine and chalcone derivatives containing thiobarbituric acid or 2-thioxo-4- thiazolidinone, Eur. J. Med. Chem. 56 (2012) 203−209. 26. V. Sharma, G. Singh, H. Kaur, A.K. Saxena, M.P.S. Ishar, Synthesis of β-ionone derived chalcones as potent antimicrobial agents, Bioorg. Med. Chem. Lett. 22 (2012) 6343−6346. 27. K. Liaras, A. Geronikaki, J. Glamoclija, A. Ciric, M. Sokovic, Novel (E)-1-(4-methyl-2-(alkylamino)thiazol-5-yl)-3-arylprop- 2-en-1-ones as potent antimicrobial agents, Bioorg. Med. Chem. 19 (2011) 7349−7356. 28. X.F. Liu, C.J. Zheng, L.P. Sun, X.K. Liu, H.R. Piao, Synthesis of new chalcone derivatives bearing 2,4 thiazolidinedione and benzoic acid moieties as potential anti-bacterial agents, Eur. J. Med. Chem. 46 (2011) 3469−3473. 29. B.P. Bandgar, S.A. Patil, B.L. Korbad, S.H. Nile, C.N. Khobragade, Synthesis and biological evaluation of β-chloro vinyl chalcones as inhibitors of TNF-α and IL-6 with antimicrobial activity, Eur. J. Med. Chem. 45 (2010) 2629−2633. 30. D. Batovska, S. Parushev, B. Stamboliyska, I. Tsvetkova, M. Ninova, H. Najdenski, Examination of growth inhibitory properties of synthetic chalcones for which antibacterial activity was predicted, Eur. J. Med. Chem. 44 (2009) 2211−2218.